Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 5, 2008, Pages 665-670

  Viswanathan, Sangeetha ^a   Kumar, R Krishna ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Catheter intervention; Congenital heart disease; Pulmonary vascular obstructive disease; Surgery

Indexed keywords

NITRIC OXIDE; OXYGEN;

CLINICAL EXAMINATION; CONGENITAL HEART DISEASE; HEART CATHETERIZATION; HEART LEFT RIGHT SHUNT; HEART SEPTUM DEFECT; HEMODYNAMICS; HUMAN; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; MEDICAL DECISION MAKING; NON INVASIVE MEASUREMENT; PREOPERATIVE EVALUATION; REVIEW;

BALLOON OCCLUSION; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIAC SURGICAL PROCEDURES; CORONARY CIRCULATION; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; LUNG; NITRIC OXIDE; OXYGEN; PATIENT SELECTION; PULMONARY ARTERY; PULMONARY CIRCULATION; REGIONAL BLOOD FLOW; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 42249112121     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21446     Document Type: Review

References (20)

1. Walker WJ, Garcia-Gonzalez E, Hall R, Czarnecki SW, Franklin RB, Das SK, Cheitlin MD. Interventricular septal defect: Analysis of 415 catheterised cases, ninety with serial hemodynamic studies. Circulation 1965;31:54-65.
2. Tynan M, Anderson RH. Ventricular Septal Defect. Paediatric Cardiology, 2nd ed. Edinburgh, Scotland: Churchill Livingstone; 2002. pp 983-1014.
3. Alt B, Shikes RH. Pulmonary hypertension in congenital heart disease: irreversible vascular changes in young infants. Pediatr Pathol 1983;1:423-434.
4. Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, Zabal C, de Lezo JS, Cao QL, Hijazi ZM. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006;68:620-628.
5. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K, Sekine E, Brown JW. Pulmonary hypertension after operation for congenital heart disease: Analysis of risk factors and management. J Thorac Cardiovasc Surg 1996;112:1600-1609.
6. Momma K, Takao A, Ando M, Nakazawa M, Takamizawa K. Natural and post operative history of pulmonary vascular obstruction associated with ventricular septal defect. Jpn Circ J 1981;45:230-237.
7. Sivakumar K, Anil SR, Rao SG, Shivaprakash K, Kumar RK. Closure of muscular ventricular septal defects guided by en face reconstruction and pictorial representation. Ann Thorac Surg 2003;76:158-166.
8. Kowalsky RH, Newburger JW, Rand WM, Castañeda AR. Factors determining access to surgery for children with congenital cardiac disease in Guatemala, Central America. Cardiol Young 2006;16:385-391.
9. Fried R, Falkovsky G, Newburger J, Gorchakova AI, Rabinovitch M, Gordonova MI, Fyler D, Reid L, Burakovsky V. Pulmonary arterial changes in patients with ventricular septal defects and severe pulmonary hypertension. Pediatr Cardiol 1986;7:147-154.
10. Frescura C, Thiene G, Giulia Gagliardi M, Mazucco A, Pellegrino PA, Daliento L, Biscaglia S, Carminati M, Gallucci V. Is lung biopsy useful in surgical decision making in congenital heart disease? Eur J Cardiothorac Surg 1991;5:118-122.
11. Yamaki S, Ogata H, Haneda K, Mohri H. Indications for open lung biopsy in patients with ventricular septal defect and/or patent ductus arteriosus and pulmonary hypertension. Heart Vessels 1990;5:166-171.
12. Kannan BR, Sivasankaran S, Tharakan JA, Titus T, Ajith Kumar VK, Francis B, Krishnamoorthy KM, Harikrishnan S, Padmakumar R, Nair K. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance. Indian Heart J 2003;55:161-166.
13. Therrien J, Rambihar S, Newman B, Siminovitch K, Langleben D, Webb G, Granton J. Eisenmenger syndrome and atrial septal defect: Nature or nurture? Can J Cardiol 2006;22:1133-1136.
14. Steele PM, Fuster V, Cohen M, Ritter DG, Mc Goon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease - Long term follow up and prediction of outcome after correction. Circulation 1987;76:1037-1042.
15. Keane JF, Lock E. Hemodynamic evaluation of congenital heart disease. In: Lock JE, Keane JF, Perry SB. editors. Diagnostic and Interventional Catheterisation in Congenital Heart Disease. 2nd ed. Boston: Kluwer Academic; 2000. pp 37-72.
16. Lock JE, Einzig S, Bass JL, et al. The pulmonary vascular response to supplemental oxygen and its influence on operative results in children with ventricular septal defect. Pediatr Cardiol 1982;3:41-46.
17. Post MC, Janssens S, Van de Werf, Budts W. Responsiveness to inhaled nitric oxide is a predictor of mid term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Eur Heart J 2004;25:1651-1656.
18. Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC, Kaine SF, Ivy D, Webber SA, Rothman A, Ross RD, Aggarwal S, Takahashi M, Waldman JD. Inhaled nitric oxide as a preoperative test (INOP Test I): The INOP Test Study Group. Circulation 2002;106:76-81.
19. Roy A, Juneja R, Saxena A. Use of Amplatzer ductal occluder to close severely hypertensive ducts: utility of transient balloon occlusion. Indian Heart J 2005;57:332-336.
20. Yan C, Zhao S, Jiang S, Xu Z, Huang L, Zheng H, Ling J, Wang C, Wu W, Hu H, Zhang G, Ye Z, Wang H. Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart 2007;93:514-518.